Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.
Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Mylan Institutional, Inc. (d.b.a. UDL Laboratories) to request your refund or repair — edit it as you like.
Subject: Recall D-166-2013 — Mylan Institutional, Inc. (d.b.a. UDL Laboratories) Mylan Institutional, Inc. (d.b.a. UDL Laboratori Hello, I own a Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg; 100 Tablets (5 x 20), 5 cards each containing 20 that is covered by recall D-166-2013 from Mylan Institutional, Inc. (d.b.a. UDL Laboratories). I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
